top of page

Home
CRO
Site Selection
- Pre-feasibility
- Environmental assessment
- Patient Journey Overview
- Sites Recommendation
- Sites Selection / Qualification visit
Monitoring Activities
- Site Initiation Visits (SIV)
- Interim Monitoring

Visits (IMV)
- Close-Out Visits (COV)
- Site Management
Startup/Regulatory
- Protocol and Investigator Brochure
- Informed Consent Form (ICF)
- CRF/eCRF
- Identify and Recruit Investigational Sites
- Qualify Sites
- Randomization Services
- Study Medication Management
- Management of Other Clinical Supplies
- Electronic Trial Master File
- Regulatory Gap Analysis & Submissions
- Ethical Submissions
Patient Recruitment
- Patient Support Program
- Medical monitor review for pre-screening
- Support for patient identification
- Engagement of sites and referral institutions
- Medical education and disease awareness initiatives
- Meaningful reduction of the gap between site activation and FPI
- Patient concierge services
Therapeutic Areas
- Rare Diseases
- Cell and Gene Therapy
- Oncology
- Infectious Diseases
- Hematology
- Ophthalmology
- Nephrology
- Neurology
- Cardiovascular
- GI and Hepatology
- Endocrinology
- Allergy and Respiratory
- Rheumatology
Commercialization
Expertise
Early Access
Commercialization
Regulatory Hosting
-Rare and Ultrarare Diseases

-High Complexity Diseases
- Post Trial Supply

- Patient Help Desk (PHD Program)

- Importation Support

- Brokerage Services

- Logistic Support
- Patient Support Program

- Diagnosis Support Program

- Pharmacovigilance

- Importation & Exportation Support

- Brokerage Services

- Logistic Support
- Market Authorization
- Sanitary Vigilance Support
- Pricing and Reimbursement
Quality Assurance
- Supply and Handling Controls
- Qualification, Audits, and Inspections
Why LATAM
Ethnically

Diverse Population
High Standard Regulation
Medical Infrastructure
learn more
Untapped Opportunity
Careers
Empowering Progress in Healthcare

Our mission is to enact positive change for patients.

Come join our team!
Click the button below to learn more about open positions and send your CV:
learn more
Contact
Please feel free to reach out!

You can send an e-mail to bd@odclifesciences.com
Or click the button below to learn more about our contact details and send an e-form:
learn more

News

New Clinical Research Law in Brazil: Innovation, Agility, and Ethics

Jun 18, 20242 min read

New Clinical Research Law in Brazil: Innovation, Agility, and Ethics

Chamber of Deputies (Brazil) Law No. 14,874, enacted on May 28, 2024, represents a significant milestone in the regulation of clinical...

102 views0 comments

Celebrating Nurse's Day: A Tribute from ODC Life Sciences

Jun 18, 20242 min read

Celebrating Nurse's Day: A Tribute from ODC Life Sciences

Florence Nightingale On May 12th, the world celebrates the nursing professionals on a significant date that not only honors these...

28 views0 comments

AACR Review - Observed Trends in Cancer Research

May 23, 20242 min read

AACR Review - Observed Trends in Cancer Research

The 2024 American Association for Cancer Research (AACR) Annual Meeting was held in San Diego, California, April 5th - 10th. Although its...

28 views0 comments

Women in Science

May 23, 20244 min read

Women in Science

Panorama Jaqueline Goes de Jesus - Brazilian biomedical scientist responsible for coordinating the team that carried out the sequencing...

10 views0 comments

ACCESSIBLE PATIENT COMMUNITIES: A TWO-YEAR EVOLUTION IN LATAM’S RARE DISEASE LANDSCAPE, FOCUS IN BRAZIL, MEXICO, ARGENTINA, AND COLOMBIA

Mar 8, 20244 min read

ACCESSIBLE PATIENT COMMUNITIES: A TWO-YEAR EVOLUTION IN LATAM’S RARE DISEASE LANDSCAPE, FOCUS IN BRAZIL, MEXICO, ARGENTINA, AND COLOMBIA

"The past two years have marked a transformative period in Latin America's approach to rare diseases due to the rise of accessible...

84 views0 comments

FDA REQUIREMENTS FOR DIVERSITY INCLINICAL TRIALS: LATAM OPPORTUNITY

Mar 8, 20243 min read

FDA REQUIREMENTS FOR DIVERSITY INCLINICAL TRIALS: LATAM OPPORTUNITY

When developing a new drug, Clinical Trials and their phases are crucial to understanding the drug's safety profile, efficacy, and...

24 views0 comments

BRAZIL AIMS FOR TOP 10 SPOT IN CLINICAL RESEARCH

Mar 8, 20243 min read

BRAZIL AIMS FOR TOP 10 SPOT IN CLINICAL RESEARCH

A new bill has been hailed as a “significant step” towardsharmonizing rules in clinicalresearch and promoting safeand ethical scientific...

38 views0 comments

bottom of page